Latest Moderna Inc News

FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. (AP Photo/Hans Pennink)

Debate begins for who's first in line for COVID-19 vaccine

Aug. 2, 2020 7:05 AM EDT

Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National...

Leon McFarlane a research technician handles a blood sample from a volunteer in the laboratory at Imperial College in London, Thursday, July 30, 2020. Imperial College is working on the development of a COVID-19 vaccine. Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in those vaccinated so far. Dr. Robin Shattock told the Associated Press that he and colleagues had just finished a very slow and arduous process of testing the vaccine at a low dose in a small number of participants and would now be expanding the trial to about 300 people, including those over 75. (AP Photo/Kirsty Wigglesworth)

UK scientists to immunize hundreds with coronavirus vaccine

Jul. 30, 2020 3:50 PM EDT

LONDON (AP) — Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. Dr. Robin Shattock, a professor at the college, told The Associated Press...

People wearing face masks to protect against the coronavirus wait to cross an intersection in Beijing, Saturday, July 25, 2020. China on Saturday reported several dozen new confirmed coronavirus cases, including a few who caught the virus abroad. (AP Photo/Mark Schiefelbein)

The Latest: New virus cases rise in China's Xinjiang region

Jul. 27, 2020 9:34 PM EDT

BEIJING — New coronavirus cases continue to rise in China’s northwestern region of Xinjiang, with 57 reported on Tuesday. The capital Beijing also reported its first case of domestic transmission in more than two weeks, while the northeastern province of Liaoning added another six cases in its local...

Nurse Carolyn Grausgruber gives volunteer Ithaca firefighter Wade Bardo, of Erin, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink)

Experimental COVID-19 vaccine is put to its biggest test

Jul. 27, 2020 8:28 PM EDT

The biggest test yet of an experimental COVID-19 vaccine got underway Monday with the first of some 30,000 Americans rolling up their sleeves to receive shots created by the U.S. government as part of the all-out global race to stop the pandemic. The glimmer of hope came even as Google, in one of the gloomiest...

President Donald Trump speaks during a coronavirus briefing at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)

Trump seeks political shot in the arm in vaccine push

Jul. 27, 2020 6:24 PM EDT

WASHINGTON (AP) — President Donald Trump’s handling of the coronavirus pandemic put his political fate in grave jeopardy. Now he’s hoping to get credit for his administration’s aggressive push for a vaccine -– and crossing his fingers that one gets approved before Election Day. ...

Moderna, SAP rise; Hasbro, Ventas fall

Jul. 27, 2020 4:19 PM EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday: Moderna Inc., up $6.70 to $79.91. The biotechnology company secured more U.S. funding for development of its potential coronavirus vaccine and started a large study. SAP SE, up $6.25 to $164.87. The software giant will spin off...

Nurse Kath Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc.,  gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink)

Virus vaccine put to final test in thousands of volunteers

Jul. 27, 2020 10:43 AM EDT

The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government -- one of several candidates in the final stretch of the global vaccine race. There’s still no guarantee that the experimental vaccine,...

File- This Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York.  The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech.  (AP Photo/Richard Drew, File)

US signs contract with Pfizer for COVID-19 vaccine doses

Jul. 22, 2020 6:31 PM EDT

WASHINGTON (AP) — The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, Health and Human Services Secretary Alex Azar announced Wednesday. The U.S. could buy another 500 million doses under...

A man wearing a face mask looks at an electronic stock board showing Japan's Nikkei 225 index at a securities firm in Tokyo Wednesday, July 22, 2020. Shares were mixed in Asia on Wednesday, with Australia’s benchmark down more than 1% on reports of a sharp rise in coronavirus cases in the Melbourne area. (AP Photo/Eugene Hoshiko)

Asian shares mixed after lackluster session on Wall Street

Jul. 21, 2020 11:15 PM EDT

MITO, Japan (AP) — Shares were mixed in Asia on Wednesday, with Australia’s benchmark down more than 1% on reports of a sharp rise in coronavirus cases in the Melbourne area. Benchmarks rose in Tokyo, Shanghai and Seoul but fell in Hong Kong. Adding to unease was a report by the U.S. Centers for...

A man wearing a face mask stands next to a bank's electronic board showing the Hong Kong share index in Hong Kong Tuesday, July 21, 2020. Asian shares were mostly higher Tuesday as hopes rose about a vaccine being developed to fight the coronavirus pandemic.(AP Photo/Vincent Yu)

Asia shares rise on vaccine hopes, tech rally on Wall Street

Jul. 20, 2020 11:53 PM EDT

Asian shares were mostly higher Tuesday on rising hopes for an effective vaccine to fight the coronavirus pandemic. Scientists at Oxford University reported that their experimental coronavirus vaccine prompted a protective immune response in hundreds of people who got the shot in an early trial. Other projects...